These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
863 related articles for article (PubMed ID: 19722158)
1. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast. Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of vascular endothelial growth factor (VEGF) does not correlate with microvessel density in renal cell carcinoma. Raica M; Cimpean AM; Anghel A Neoplasma; 2007; 54(4):278-84. PubMed ID: 17822316 [TBL] [Abstract][Full Text] [Related]
3. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related]
4. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. Lee AH; Dublin EA; Bobrow LG; Poulsom R J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC; Bleil CB; Hilbig A; Coutinho LM Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830 [TBL] [Abstract][Full Text] [Related]
6. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868 [TBL] [Abstract][Full Text] [Related]
7. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
8. Study of angiogenesis in invasive breast carcinoma by morphometry and immunohistochemistry. Bhatia JK; Chaudhary T; Boruah D; Bharadwaj R Med J Armed Forces India; 2022 Jul; 78(3):345-354. PubMed ID: 35855704 [TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor in invasive ductal carcinoma of the breast and the relation to angiogenesis and p53 and HER-2/neu protein expression. Lee JS; Kim HS; Jung JJ; Kim YB; Lee MC; Park CS Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):289-95. PubMed ID: 12607595 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and VEGF expression in pre-invasive lesions of the human breast. Viacava P; Naccarato AG; Bocci G; Fanelli G; Aretini P; Lonobile A; Evangelista G; Montruccoli G; Bevilacqua G J Pathol; 2004 Oct; 204(2):140-6. PubMed ID: 15376259 [TBL] [Abstract][Full Text] [Related]
11. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. Yang LY; Lu WQ; Huang GW; Wang W BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286 [TBL] [Abstract][Full Text] [Related]
12. Angiogenesis in the progression of breast ductal proliferations. Carpenter PM; Chen WP; Mendez A; McLaren CE; Su MY Int J Surg Pathol; 2011 Jun; 19(3):335-41. PubMed ID: 19403546 [TBL] [Abstract][Full Text] [Related]
13. [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance]. Wang XB; Yang QX; Pei XJ Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):860-3. PubMed ID: 16793622 [TBL] [Abstract][Full Text] [Related]
14. [Relevance of tumor angiogenesis in occurrence and development of breast cancer]. Liu Y; Wang G; Xu WG; Song JN; Yang XQ; Wang WY Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1687-9. PubMed ID: 19957527 [TBL] [Abstract][Full Text] [Related]
15. Microvessel density assessment in benign and malignant endometrial changes. Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753 [TBL] [Abstract][Full Text] [Related]
16. Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors: Angiogenic markers and prognosis in pediatric ACTs. Dias AI; Fachin CG; Avó LR; Frazão CV; Caran EM; Schettini ST; Alves MT; Ribeiro RC; Abib Sde C J Pediatr Surg; 2015 Aug; 50(8):1323-8. PubMed ID: 25783314 [TBL] [Abstract][Full Text] [Related]
17. Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. Bolat F; Kayaselcuk F; Nursal TZ; Yagmurdur MC; Bal N; Demirhan B J Exp Clin Cancer Res; 2006 Sep; 25(3):365-72. PubMed ID: 17167977 [TBL] [Abstract][Full Text] [Related]
18. Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma. Valković T; Dobrila F; Melato M; Sasso F; Rizzardi C; Jonjić N Virchows Arch; 2002 Jun; 440(6):583-8. PubMed ID: 12070596 [TBL] [Abstract][Full Text] [Related]
19. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy. Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. Ludovini V; Sidoni A; Pistola L; Bellezza G; De Angelis V; Gori S; Mosconi AM; Bisagni G; Cherubini R; Bian AR; Rodinò C; Sabbatini R; Mazzocchi B; Bucciarelli E; Tonato M; Colozza M Breast Cancer Res Treat; 2003 Sep; 81(2):159-68. PubMed ID: 14572158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]